Genentech, MoFo fend off Eli Lilly’s $10 mln fee bid in psoriasis drug patent case

… but it wasn’t weak enough to justify attorneys’ fees under patent law’s “exceptional case” standard, U.S. District Judge Janis Sammartino ruled.